StockData
Glucose Health, Inc. logo

Glucose Health, Inc. (GLUC) stock

GLUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2017, quarter ended Sep 30, 2017Last filing: 10-Q on Nov 14, 2017
$0.44+0.10 (+28.76%)

Close on Oct 19, 2026Market cap $1.82MP/E –Yield –

Glucose Health r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2015 it was $48, down 98.8% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2015Dec 31, 2015$48-98.8%
FY2014Dec 31, 2014$4.00K–

More Glucose Health figures

See a number that looks wrong?